PAV-220830FLY-756

samples-publishAS-BCG_PAV.xlsx

PAV-220830FLY-756

4919-190611

NHP-220830FLY-11

anti-cd4 infusion premed. , pre-dosing vitals; HR 140, RR 36, T 100.5. Interim vitals; HR 150, RR 36, T 100. End of infusion vitals; HR 140, RR 36, T 199.8. No adverse reactions. , anti-cd4 infusion premed

https://fairdomhub.org/sops/795

Blood; Treatment

Complete Blood Count Blood Test; Fluorescence Activated Cell Sorting

Flynn Lab

2019-06-11 00:00:00

JoAnne Flynn

Acetaminophen

Medication

Orally

80

milligram

Anti CD4

Antibody

Intravenously

260(25milliliter)

milligram

Diphenhydramine

Medication

Intramuscularly

6

milligram

Not specified

Not specified

Not specified

Not specified

Not specified

Not specified

Not specified

Not specified

Not specified

Not specified

Not specified

AB-220907FLY-2

Not specified

Not specified

help Creators and Submitter
Creators
Not specified
Submitter
Activity

Views: 9

Created: 3rd Feb 2025 at 21:09

Last updated: 4th Feb 2025 at 00:36

help Tags

This item has not yet been tagged.

help Attributions

None

Powered by
(v.1.16.1)
Copyright © 2008 - 2024 The University of Manchester and HITS gGmbH